Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$55.64M-12.4%-$47.51M-9.7%-$52.9M-21.1%-$46.63M-44.5%-$49.5M+65.0%
$23.1M+79.6%$19.27M+82.5%$18.81M+71.0%$15.88M+53.3%$12.86M+65.6%
-$44.19M-9.5%-$25.39M-34.7%-$26.62M-5.6%-$23.31M+19.8%-$40.35M+1.0%
$57.05M+130%-$246.35M-171%$54.04M$24.81M-17.4%
$4.29M-7.1%$5.4M+41.8%$5.57M+67.0%$4.33M+45.7%$4.62M+65.8%
-$5.4M-117%$189.3M+7,496%$32.5M+666%
$7.92M-53.3%$0-100%-$83.36M+27.0%$29.55M-72.7%$16.96M+360%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rhythm Pharmaceuticals, Inc. generate?
Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.